Search clinical trials for: Nemolizumab
Total 18 results
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
Galderma R&DCompleted
-
Galderma R&DCompletedAtopic DermatitisUnited States, Bulgaria
-
Maruho Co., Ltd.Active, not recruiting
-
Galderma R&DCompletedChronic Kidney Disease Associated Moderate to Severe PruritusSpain, United States, Hungary, Poland
-
Galderma R&DCompletedPrurigo NodularisUnited States, Germany, Austria, Canada, Denmark, Hungary, Italy, Poland, Sweden, United Kingdom
-
Galderma R&DActive, not recruitingPrurigo NodularisUnited States, Belgium, Canada, France, Korea, Republic of, Netherlands, Poland, Spain, Switzerland, Austria, Denmark, Germany, Hungary, Italy, Sweden, United Kingdom
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Galderma R&DWithdrawn
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Galderma R&DCompletedPrurigo NodularisUnited States, Austria, France, Germany, Poland, Korea, Republic of, Switzerland
-
Galderma R&DCompletedPrurigo NodularisUnited States, Belgium, Canada, France, Korea, Republic of, Netherlands, Poland, Spain, Switzerland
-
Galderma R&DCompletedAtopic DermatitisUnited States
-
Galderma R&DCompleted
-
Chugai PharmaceuticalCompleted
-
Galderma R&DCompleted
-
Galderma R&DCompletedAtopic DermatitisUnited States, France, Poland, Germany, Australia, Canada